ArticleMolecular therapy oncolytics2022

Combination microRNA-based cellular reprogramming with paclitaxel enhances therapeutic efficacy in a relapsed and multidrug-resistant model of epithelial ovarian cancer.

Srujan K Gandham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.